PBAC Public Summary Document - November 2013
Public Summary Documents relating to the November 2013 PBAC meeting.
- ADALIMUMAB, 40mg/0.8mL injection, 0.8 mL cartridges and 0.8mL syringes, Humira®
- ALOGLIPTIN with METFORMIN, tablet, 12.5mg/500mg, 12.5mg/850mg, 12.5mg/ 1000mg, Nesina Met®
- AXITINIB, tablet, 1 mg and 5 mg, Inlyta®
- BEVACIZUMAB, solution for IV use, 100mg in 4mL and 400mg in 16mL, Avastin®
- BOTULINUM TOXIN TYPE A, 100 units injection, vial, Botox®
- CINACALCET, tablets, 30 mg, 60 mg and 90 mg, Sensipar®
- CLOBETASOL PROPIONATE, shampoo, 500 microgram per mL, 125mL
- CRIZOTINIB, 200 mg and 250 mg, capsule, Xalkori®
- DENOSUMAB, solution for injection, 120 mg in 1.7 mL, Xgeva®
- DOLUTEGRAVIR, tablet, 50 mg, Tivicay®
- ERIBULIN MESILATE, injection in vial, 1mg/2mL Halaven®
- EXENATIDE, powder for injection, 2 mg, Bydureon®
- EZETIMIBE and ROSUVASTATIN, pack containing 30 tablets ezetimibe 10 mg, and 30 tablets rosuvastatin 5 mg, 10 mg, 20 mg or 40 mg, Rosuzet® Composite Pack
- FERRIC CARBOXYMALTOSE, solution for I.V. use, 500mg in 10mL, Ferinject®
- FIRST-LINE ANTI-RETROVIRAL THERAPY (ART)
- GLYCOPYRRONIUM BROMIDE, powder for inhalation, 50 microgram, Seebri®, Breezhaler®
- INFLIXIMAB, powder for intravenous infusion, 100mg, Remicade®
- IVACAFTOR, tablet, 150mg, Kalydeco®
- METFORMIN and SAXAGLIPTIN, tablet, 1,000mg/2.5mg, 1,000mg/5mg, 500mg/5mg, Kombiglyze® XR
- METFORMIN and SITAGLIPTIN, tablet, 1000mg/50mg, 1000mg/100mg, Janumet® XR
- MULTICOMPONENT MENINGOCOCCAL GROUP B VACCINE, 0.5mL, injection, prefilled syringe, Bexsero®
- PANITUMUMAB, 100 mg/5 ml and 400 mg/20 ml injection, Vectibix®
- PLERIXAFOR 24 mg/1.2 mL, injection, subcutaneous infusion, 1.2 mL vialMozobil®
- RANIBIZUMAB (DME), solution for intravitreal injection, 2.3 mg in 0.23 mL, Lucentis®
- RANIBIZUMAB (RVO), solution for intravitreal injection, 2.3 mg in 0.23 mL, Lucentis®
- SORAFENIB, tablet, 200 mg, Nexavar®
- TAPENTADOL, tablet, 50mg, 100mg, 150mg, 200mg and 250mg (as hydrochloride) (sustained release), Palexia SR®
- TOBRAMYCIN, inhalation, powder for, capsules 28 mg, Tobi® Podhaler®
- TOCILIZUMAB, concentrate for injection, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra®
